When human CD48-Fc Chimera is immobilized at 5 µg/mL, biotinylated human SLAMF4-Fc Chimera binds with EC50 of 0.75 - 3 µg/mL. HRP Avidin (Cat. No. 405103) was used to detect the binding.

Recombinant Human CD48 (SLAMF2)-Fc Chimera (carrier-free)

Cat No.  788702, 788704, 788706, 788708

Source :

Human CD48, amino acid Gln27-Ser220 (Accession # P09326.2), with a linker (GSSR) and a C-terminal human IgG (Pro100-Lys330), was expressed in 293E cells.

Activity :
When recombinant human CD48-Fc Chimera is immobilized at 5 µg/mL, biotinylated human SLAMF4-Fc Chimera binds with EC50 of 0.75 - 3 µg/mL. HRP Avidin (Cat. No. 405103) was used to detect the binding.

Recombinant human FGF-basic (154 aa) induces the proliferation of NIH/3T3 cells in a dose-dependent manner. The ED50 for this effect is 0.02 - 0.1 ng/mL.

Recombinant Human FGF-basic (154 aa) (carrier-free)

Cat No. 788402, 788404

Source :

Human FGF-basic (154 aa), amino acid Ala135-Ser288 (Accession # P09038) was expressed in E.coli. The amino terminal contains Met.

Activity :

Recombinant human FGF-basic (154 aa) induces the proliferation of NIH/3T3 cells in a dose-dependent manner. The ED50 for this effect is 0.02 - 0.1 ng/mL